PCM
AERI

PenderFund Capital Management’s Aerie Pharmaceuticals AERI Stock Holding History

PenderFund Capital Management’s Portfolio AERI Stock Details AERI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-22,950
Closed -$480K – 176
2022
Q3 		$480K Buy
+22,950
New +$267K 0.15% 77

PenderFund Capital Management's AERI Position: Q4 2022 in Review

PenderFund Capital Management sold out of Aerie Pharmaceuticals (AERI) in Q4 2022, closing a stake of 22,950 shares — an estimated $480K sold.

PenderFund Capital Management first reported a position in AERI in Q3 2022 and held it in 1 quarter. The position peaked at $480K in Q3 2022. 0 funds tracked by Wall St. Rank hold AERI as of Q4 2022.

  • PenderFund Capital Management reported no remaining Aerie Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • PenderFund Capital Management sold 22,950 Aerie Pharmaceuticals shares in Q4 2022, an estimated $480K.
  • PenderFund Capital Management first reported a position in Aerie Pharmaceuticals in Q3 2022 and held it in 1 quarter.
  • PenderFund Capital Management's Aerie Pharmaceuticals position peaked at $480K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2022.

Based on PenderFund Capital Management's 13F filing for Q4 2022, filed 10 Feb 2023.